Drugs / bezaydamine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 0 | NCT05034068 Comparator | Oct 2021 → Jan 2022 | stomatitis | Al-Azhar University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | bezaydamine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05034068 ↗ |
| Route | Topical | “0.15% bezaydamine hydrochloride was applied in oral mucosa” NCT05034068 ↗ |